Background: Orofacial clefts are the most common malformations of the head and neck, with a worldwide prevalence of 1 in 700 births. They are commonly divided into CL(P) and CP based on anatomic, genetic, and embryologic findings. A Nigerian craniofacial anomalies study (NigeriaCRAN) was set up in 2006 to investigate the role of gene-environment interaction in the origin of orofacial clefts in Nigeria.
In spite of better quality health care access in developed countries, mortality due to birth defects accounts for an increasing proportion of infant mortality (30% to 50% of perinatal deaths and 20% to 30% of infant mortality) (World Health Organization, 2005) . Neonatal death is an issue in sub-Saharan Africa that cannot be ignored, with rates in many places more than 10 times greater than those in developed countries. Causes are multiple and include infectious disease (human immunodeficiency virus [HIV]/ acquired immunodeficiency syndrome [AIDS] , tuberculosis, and malaria), malnutrition, poverty, and the possibility of infanticide in those born with congenital birth defects such as orofacial clefts (Strauss, 1985; Akinmoladun et al., 2007) .
Orofacial clefts (OFCs) require complex multidisciplinary treatment and are associated with elevated infant mortality and significant lifelong morbidity. The development of craniofacial structures is an exquisitely orchestrated process involving the coordinated growth of multiple, independently derived primordia. Perturbations impacting on the growth of these primordia may interfere with the proper morphogenesis of facial structures, resulting in clefting of the lip or the primary or secondary palate, or a combination of these sites .
Clefts of the lip and/or palate are the most frequent congenital malformation of the head and neck, with a combined overall prevalence of approximately 1 in 700 (World Health Organization, 2001) . With variation between ethnic groups and geographic regions, high rates are reported for cleft lip with or without cleft palate (CL[P]) in parts of Latin America and Asia (China, Japan) and low in Israel, South Africa, and southern Europe. Rates of isolated cleft palate are high in Canada and parts of northern Europe and low in parts of Latin America and South Africa ).
In sub-Saharan Africa, the prevalence of orofacial cleft remains uncertain because of lack of data; the few reported studies suggest that the prevalence is low compared with rates reported in other continents. However, caution must be exercised in comparing rates of other continents with those of Africa because of differences in ascertainment, sample sizes, and analysis methods (Butali and Mossey, 2009) . Although studies on the prevalence of clefts are limited, several reports in the literature describe the care and management of orofacial clefts in Nigeria (Onah et al., 2008; Olasoji et al., 2009) .
Recent advances in knowledge of the origin of OFC have led to strong evidence and a significant association with polymorphisms in certain candidate genes, including interferon regulatory factor six (IRF6) (Zucchero et al., 2004; Rahimov et al., 2008) , forkehead boxE1 (FOXE1) (Marazita at al., 2004; Moreno et al., 2009) , and muscle segment homeobox (MSX1) (Sakatoka and Maas, 1994; Jezewski et al., 2003; Suzuki et al., 2004; Modesto et al., 2006; Tongkobpetch et al., 2006) .
The first genome-wide association study (GWAS) on CL/ P identified genetic susceptibility for nonsyndromic CL(P) on chromosome 8q24.21 (Birnbaum et al., 2009 ). Consistent with the findings of Birnbaum et al. (2009) , another GWAS identified genetic susceptibility on chromosome 8q24 among nonsyndromic CL(P) cases (Grant et al., 2009) . Both studies used individuals of European ancestry. In a recent expansion of the number of samples used in the Birnbaum paper, a GWAS carried out by Mangold et al. (2010) reported two new loci associated with nonsyndromic cleft lip and palate (NSCL/P) at 17q22 and 10q25.3 (Mangold et al., 2010) .
GWAS carried out by Beaty et al. (2010) for CL/P replicated the evidence of association at a genome-wide level of significance (i.e., p value , 5 3 10 28 ) for singlenucleotide polymorphisms (SNPs) on chromosome 8q24 and IRF6. In addition, the study identified several other loci that showed evidence of association attaining genomewide significance for two loci (ABCA4 on chromosome 1p22.1, MAFB on chromosome 20q12) and was strongly suggestive for PAX7 on chromosome 1p36, VAX1 on chromosome 10q25.3, and NTN1 on chromosome 17p13.
Other candidate genes that have been reported to play a role in clefting include bone morphogenetic protein (BMP4) (Suzuki et al., 2009) , tumor protein 63 (TP63) (Scapoli et al., 2008) , Jagged 2 gene (JAG2) (Vieira et al., 2005; Scapoli et al., 2008) , fibroblast growth factors and their receptors (FGFs, FGFRs) (Riley et al., 2007) , and poliovirus receptor related 1 (PVRL 1) (Avila et al., 2005; Turhani et al., 2005) . All these candidate gene studies and genetic analyses serve to inform the current study of oral facial clefting in the Nigerian population.
The current study investigated the role of these candidate genes and potential environmental influences in the origin of orofacial cleft in the Nigerian population using a casecontrol study design. Direct sequencing and genotyping were used to evaluate the role of a selected group of candidate genes among Nigerian probands.
MATERIALS AND METHODS

Patient and Control Recruitment
Ascertainment of eligible cases was completed through the free surgical repairs project sponsored by a United Statesbased charity, Smile Train. All participating centers in the NigeriaCRAN project are Smile Train partners, and this link ensured recruitment of eligible patients. Before the Smile Train support was obtained, the financial burden associated with surgical costs was a limiting factor to recruitment.
Subjects were ascertained through the Nigerian craniofacial anomalies project (NigeriaCRAN); a multi-center collaboration between the University of Dundee, Scotland and 11 hospitals in Nigeria. 1 All participating hospitals obtained ethical permission. Eligible infants were those born between September 1, 2006, and August 31, 2008, to Nigerian parents in Nigeria. Births from Caucasians, Asians, and residents of other African countries were excluded. Nigerian children born with cleft lip and palate from the September 1, 2006 , to August 31, 2008 , in Nigeria and their parents were included from the study as cases. During the cleft clinic visit, children were reviewed by the cleft surgeon; diagnosis was confirmed, and any recognized or diagnosed syndromes excluded. Controls were Nigerian children born alive with no congenital birth defects after September 1, 2006, in Nigeria and their parents. These children were examined by a pediatrician to ensure that they did not have any congenital birth defects.
A protocol of two controls to one case was implemented, and controls were matched to cases by birth month and year and gender. Controls were recruited in five centers located across the five geopolitical regions and representative of the areas in which cases were recruited. Every family (case and control) recruited into the study was assigned a code, which is the unique identifier number (UNID) for that family, and the study coordinator informed the designated cleft surgeon of the intention to approach the patient for the Nigeria-CRAN project. Signed informed consent was obtained from all families that participated in the study. A nurse or a surgical registrar was designated to use the study questionnaire to interview mothers to obtain information. Information obtained included maternal medical history, lifestyle, and occupational and environmental exposures, particularly in the periconceptional period (before pregnancy and first trimester). Administration of the questionnaire to case and control mothers was carried out within the first year of childbirth. The aim was to standardize the collection of information. Completed questionnaires were returned to the study coordinator in the hospital, and all completed questionnaires were checked, compiled, and forwarded on to the study coordinator in Dundee.
DNA Extraction
A saliva sample was taken from the child by the study coordinator or surgeon at the clinic or the time of surgery using saliva sponges (Oragene). Parents' saliva samples were taken by arrangement with the cleft team using the 2-mL self-collecting Oragene kits. All samples were sent directly to the Human Virology Laboratory at the Nigerian Institute of Medical Research (NIMR) in Lagos, Nigeria, for DNA extraction and storage at 220uC. Extraction of DNA was carried out according to the protocol provided by the product manufacturer (http://www.dnagenotek.com/ focus_gr_purification.htm). Following material transfer agreement, DNA samples were transferred from NIMR to the University of Iowa for candidate gene sequencing, genotyping, and analysis.
A total of 118 cases, including two cases (76 triads and 42 dyads [i.e., mother and child]) with a family history of clefts, were collected. Family cases were obtained from the mothers as part of the family history of cleft information contained in the questionnaire data, and no physical examination was carried out on relatives with clefts to ascertain types of clefts. These case individuals had the following phenotypes: 69 CL(P), 38 CL, 11 CP. Further classification of groups into types of clefts, laterality, and gender is presented in Table 1 . For a case-control comparison, the study attempted to recruit two controls per case by geopolitical region, birth month, and gender. A total of 166 control samples (164 dyads [i.e., mother and child] and two triads) were recruited from individuals at hospitals in each geopolitical zone (which represents 76.4% of the planned number of controls for the study). Table 1 shows the numbers of nonsyndromic clefts, cleft types, and controls among males and females. Overall, more cases of CL(P) (69) than CL (38) and CP (11) were reported. More males (38) with CL(P) than females (31) were identified, more cases of CL (22) were reported in females than males (16), and more females (eight) with CP (three) than males were detected. Overall, more males than females were included in the study. A total of 166 matched controls-88 males and 78 females-were recruited (70.3% recruitment rate). A significant difference between sides for CL (p 5 .03) and between bilateral clefts and clefts on either side (p 5 .02) was noted using Fisher's exact probability test. A significant gender difference was also observed for CP (p 5 .008), but no statistically significant gender difference was observed for CL (p 5 .139) using Fisher's exact probability test.
PCR and Direct Sequencing
Ten microliters of 20-ng/mL DNA was sent to the Functional Biosciences Laboratory in Madison, Wisconsin, for sequencing of the two exons of MSX1 (CR1-4). Polymerase chain reaction (PCR) conditions were initially 96uC for 5 minutes, 94uC for 30 seconds, 60uC for 45 seconds, and 72uC for 1 minute 30 seconds for 39 cycles, followed by 72uC for 5 minutes and 4uC. Two rounds of PCR amplification were carried out prior to sequencing. Samples were then sequenced in both directions to confirm variants using Big Dye 3.1 on an ABI 3730 3 l. Sequencing was attempted for the genes IRF6, FOXE1, and BMP4, but failed secondary to poor quality DNA that was likely damaged in preparation, storage, or shipment.
Genotyping
To investigate family-based associations, genotyping of case and control families was done using TaqMan technology. A total of nine candidate genes (chromosome 8q, ABCA4, BMP4, FGFR1, FGFR2, FOXE1, IRF6, MAFB, MSX1) were investigated using 18 markers (see Results, Table 4 ). The master mix contained 1.5 mL of TaqMan master mix, which is the polymerase, 0.0375 mL of TaqMan probe (the marker for each gene investigated), and 1.4625 mL of double-distilled H 2 O (ddH 2 O), making 3 mL of the master mix. At completion of the PCR process, plates were read using the 7900HT fast real-time PCR system controlled by SDS software, version 2.4 (SDS Software Solutions, West Branch, MI). All files with samples and markers were imported into Progeny, version 7.6.04 (Progeny Software LLC, Delray Beach, FL; www. progenygenetics.com/articles.html) to check for Mendelian errors and discrepancies within each file.
Statistical Analysis
The Family-Based Association Test (FBAT) was used to show evidence for linkage disequilibrium using transmission disequilibrium testing. In this test, heterozygous parents (who do not have the phenotype but may carry the genotypes) are tested to determine the percent of transmission of each of the two alleles.
RESULTS
Direct Sequencing
The two exons of MSX1 were sequenced in 59 Nigerian case probands (samples with successfully amplified DNA products following repeated PCR of the 118 cases recruited) using four primers that overlap, to ensure that the entire gene is sequenced. These were the same primers (A, B, G, and H) represented graphically (Fig. 1) by Jezewski et al. (2003) . In exon 1, one nonsynonymous missense variant (A34G) and one synonymous variant (G116G) were observed (Fig. 1) . Nine patients had the A34G missense variant, five were homozygous for the rare allele, and four were heterozygous for the wild type. The G116G variant was observed in three probands: two heterozygotes for the wild type, and one homozygote for the rare allele.
Control samples failed to amplify after several attempts following PCR; to validate the A34G variants in the Nigerian population, exon 1 was sequenced in 25 unrelated HapMap samples of Nigerian origin (Yoruba) obtained in Ibadan, the South West region of Nigeria. Four individuals had the A34G variant: two heterozygous for the wild type, and the other two homozygous for the rare type. Table 2 shows the sequencing results for MSX1 genes and conserved regions in 59 cleft cases and 25 HapMap Yoruba samples. In exon 1, a change was noted in nucleotide at position 68C.G relative to the start codon. This change is a nonsynonymous coding mutation that changes the amino acid from alanine to glycine at position 34 (A34G). In the same CR1, a change in nucleotide was noted at position 297 C.T relative to the start codon. This change is a synonymous mutation with no change in amino acid for the glycine at position 116 (G116G). Deletion of a T nucleotide was observed in nucleotide position 150 in exon 1. Table 3 shows the expected frequencies of the alleles for cases and HapMap controls calculated from observed genotypes. In these cases, significant deviation from Hardy Weinberg equilibrium (HWE) is evident (p 5 .00002). Table 4 shows allele frequencies for 88 case families and 88 control families. These are samples with complete genotype and environmental data out of the total 118 cases and 166 controls recruited. The odds ratio was calculated between cases and controls for each marker investigated using Fisher's exact test. No significant result was observed for any of the markers investigated. 
DISCUSSION
Epidemiology
The prevalence of cleft lip and palate in Africa has often been reported as low relative to other populations (Iregbulem, 1982) . However, only one birth defects surveillance system in Africa (the South African birth defects surveillance system [SABDSS]) is currently monitoring birth defects. In most studies that have reported prevalence, data were obtained from hospital records, which are often prone to bias. A systematic review by Butali and Mossey (2009) concluded that cleft lip and palate in Africa is under-ascertained. These authors suggested that ascertainment can be improved by establishing birth defects registries through collaboration among various experts involved in cleft care in Africa. Little or no research on the genetic or environmental factors associated with craniofacial anomalies has been carried out in the African population (World Health Organization, 2004) .
In the present study, incomplete ascertainment of clefts is evident; therefore this study sample is prone to biases. The proportion of CP is low, consistent with similar reports from previous studies in Africa (Iregbulem, 1982; Ogle, 1993) , and different from the findings of other studies that reported a high prevalence of CP in Northern Europe (Tolarova and Cervenka, 1998) . A high proportion of bilateral clefts can also be seen, particularly in the CL(P) group, when compared with previous literature reports citing a low prevalence (Hagberg et al., 1998) . Poorer survival and biases in referral based on severity may affect the observed rates in populations in which true birth prevalences cannot be determined. The greater number of cases of CL(P) in males, more cases of CP in females, and the CL(P) to CL ratio of 2:1 are consistent with the literature (Mossey and Little, 2002) . 
Genetic
Various ethnic groups in Nigeria believe that witchcraft, evil spirits or the devil, the mother, and occasionally the child are responsible for orofacial cleft outcomes (Oginni et al., 2010) . These cultural and ethnic beliefs may be a reason for infanticide in those born with orofacial clefts (Strauss, 1985; Akinmoladun et al., 2007) .
The present study is the first to investigate candidate genes in orofacial clefts in the African population. Although the small sample size limits statistical power, a tendency toward genetic association is evident at a few candidate gene loci.
MSX1 Sequencing
Multiple missense coding mutations within MSX1 have been identified in patients exhibiting clefting and tooth agenesis (van den Bogaard et al., 2000) , as well as in familial and sporadic nonsyndromic oral facial clefting cases (Lidral et al., 1998; Jezewski et al., 2003; Suzuki et al., 2004; Vieira et al. 2004; Tongkobpetch et al., 2006) . In addition, multiple reports have described highly penetrant MSX1 coding mutations exhibiting Mendelian inheritance of tooth agenesis (oligodontia) phenotypes (Vastardis et al., 1996; Lidral et al., 2002; De Muynck et al., 2004; Chishti et al., 2006; Xuan et al., 2008) . Finnerty et al. (2009) performed bioinformatics analysis of the Msx gene family and identified seven ancient, strongly conserved coding domains within the Msx1 orthologs. The protein domain composition of these Msx1 orthologs was found to have diverged substantially from Msx2 and Msx3 paralogs within the vertebrate lineage. Several of the known MSX1 coding mutations cited in these studies occurred at deeply conserved sites within the Msx homology (MH) domains. The A34G missense variant is found within the most divergent portion of the Msx1 sequence-upstream of the first of the MH deeply conserved domains (see Finnerty et al., 2009, Fig . 6 ).
In the human genome UCSC browser, A34G is rs36059701 found within a run of seven alanines (and one threonine at T33) on the N-terminal side of the MSX1 protein. Another polyalanine tract can be seen within MSX1 on the C-terminal side of the homeodomain. Although neither of these is a purely homopolymeric amino acid tract, they are generally conserved within Msx1 orthologs from mammalian lineages (see supplemental Fig. 1, Finnerty et al. [2009] for a curated alignment). Neither of these polyalanine tracts is found in Msx2 or Msx3 protein sequences, thus again distinguishing Msx1 from Msx2 and Msx3 in this regard.
Previous literature reports (Lavoie et al., 2003; Messaed and Rouleau, 2009 ) suggest that polyalanine tracts of a moderate size (,20 alanines) operate as protein-protein interaction domains, which are important during the formation of transcriptional complexes. Lavoie et al. (2003) also reported that these types of alanine repeats were conserved among mammals but were rarer and shorter in fish and reptiles. Thus it is conceivable that the Msx1 N-terminal polyalanine tract represents a more modern Msx1 protein motif, which evolved and stabilized during the mammalian lineage. Consistent with this possibility are previous functional analyses of the Msx1 protein, which demonstrated that the N-terminal region contributes to repression activity and augments its interaction with the general transcription complex (Catron et al., 1995; Zhang et al., 1996) . Thus the A34G missense mutation may actually be disrupting an Msx1 orthologspecific protein-protein interaction domain that is important during transcriptional repression activity.
Direct evidence for the role of the A34G variant in clefting in the present report comes from distortion of HWE on a small sample size. This result suggests that homozygotes for this variant may be overrepresented in cleft cases, even though no evidence suggests allelic distortion and thus impaired function of MSX1 dimers. Considerable genetic evidence beyond the present report supports this possibility. The A34G mutation that changes the amino acid from alanine to glycine at position 34 has been reported previously by various studies in different populations by Lidral et al. (1998;  Caucasians from Iowa), Jezewski et al. (2003; Iowan Asians [Filipinos] , South American), Vieira et al. (2004;  South Americans in Chile), Suzuki et al. (2004; Vietnamese) , and Tongkobpetch et al. (2006; Thai population) . However, as yet no population frequency data are available in the databases (DbSNP and 1000Genomes). Although this mutation has been presumed to be benign (Jezewski et al., 2003; Suzuki et al., 2004) , homozygous individuals were reported only in the Thai study (Tongkobpetch et al., 2006) .
In addition, Modesto et al. (2006) reported a significant association between this polymorphism and the disease state, even after removal of syndromic cases. Xuan et al. (2008) identified a novel coding mutation (A221E), likely in phase with the minor allele of A34G, both cosegregating with oligodontia in a three-generation pedigree. Lidral et al. (1998) reported that the fourth allele of the MSX1 intronic CA repeat was associated with clefting by case-control allele frequency comparisons, as well as by transmission disequilibrium test (TDT) and affected family-based association controls (AFBAC) nuclear family-based analyses. In this same study, investigators tested for association with several additional sequence polymorphisms, including A34G. Haplotype comparisons of CL(P) or CP probands with controls showed evidence of nearly significant LD with two different haplotypes. One of these haplotypes included the A34G minor allele. This haplotype was not found on any of the control chromosomes, leading researchers to speculate that this coding substitution may affect protein function. Modesto et al. (2006) also investigated the A34G allele among a set of patients with and without tooth agenesis (TA). The A34G substitution was observed more frequently in patients with both OFC and TA than in controls (p 5 .0008).
In the present study, nine of the case probands and four of the HapMap controls have the A34G mutation. All case individuals with the mutation have complete cleft lip and palate; these include three with bilateral CL(P), one with right CL(P), and five with left complete CL(P). The clefting status of the HapMap controls is unknown. An excess of homozygotes for the rare type was noted among the cases, along with deviation from HWE (p 5 .00002). This may stem from the small sample size in the study, ascertainment bias, or possible biological effects of the A34G missense mutation in the MSX1 gene. All these considerations suggest a role for Msx1-type polyalanine tracts within transcriptional repression complexes that may be partially disrupted by the A34G missense mutation. Additional clinical and functional studies are needed before a definite genotype-phenotype correlation can be confirmed.
Hardy Weinberg Equilibrium
Deviation from HWE was noted in the distribution of MSX1 A34G variant genotypes among case genotypes from the case-control study. This may be due to chance or to sequencing or genotyping errors; the latter two were carefully checked and repeated. It may be that A34G is acting as a weak recessive allele and is implicated in oral facial clefts.
FBAT/TDT
Comparison between markers for the 11 candidate genes investigated revealed no statistically significant difference between cases (all clefts) and controls (p . .05). This implies that there are no differences among markers between cleft cases and controls. However, the sample size and the low minor allele frequency for many of the SNPs in genes previously associated with CL/P (IRF6, MAFB) limit this statistical interpretation.
Limitation of Present Study
The present study was carried out in a single population and African ethnic group after a small number of eligible cases were recruited. Ascertainment of cases was incomplete and subgroups for analysis were inadequate; also, all clefts were analyzed in a single group. Poor quality DNA further limited some analyses. Although no definitive conclusions can be drawn from this study, it does serve as a useful introduction to the study of clefts in Africa. Sudden closures of participating hospitals during the period of the project; delays in getting collection kits; loss of patients to follow-up; and chances that cleft palate (CP) may not be detected were some of the reasons for low recruitment of cases. The NigeriaCRAN project should be replicated in other sub-Saharan countries to establish a DNA bio-bank and carry out Africa-wide whole genome scans to pick up new candidate genes.
CONCLUSION
This study is the first in sub-Saharan Africa to investigate candidate genes in the development of orofacial clefts. Epidemiologic data revealed a statistically significant difference between the frequency of occurrence of leftversus right-sided clefts (p 5 .003) and between bilateral and unilateral clefts (p 5 .02), and an excess of females with CP (p 5 .008). Replication of a missense mutation that had been reported previously in other populations suggests a role for the MSXI A34G variant in the development of CL(P) that requires further investigation.
